12:00–1:30 p.m. (EDT)
Since legalization in 2018, cannabis consumption trends continue to inform our understanding of the associated health and mental health risks.
This webinar features:
Key report from Canada’s leading voice on substance use and addiction provides evidence-based knowledge for policy makers
The Canadian Collaborative Mental Health Care Conference aims to advance collaborative practice in mental health care in primary care and community settings. Our scope includes intra- and interprofessional collaboration, as well as collaboration…
Dr. Alexander Caudarella is a bilingual family physician with specialty training in substance use health issues.
12:00–1:30 p.m. (EDT)
This webinar is a continuation of Clinical and Mental Health Implications, Part I. It builds on the themes of clinical and health implications, looking at the impact of legalization on associated…
Das, A., Hendershot, C., Husin, I., Knyahnytska, Y., Le Foll, B., Wang, W., Elsaid, S., & Kloiber, S..
In 2007, CCSA formed the Scientific Advisory Council (SAC) to inform our work of the latest scientific developments in the substance use and addiction field, to ensure that the biomedical and neuroscience perspectives…
OTTAWA (September 23, 2022): The Canadian Centre on Substance Use and Addiction (CCSA) welcomes the opportunity to contribute evidence on public health, public safety and equity that has been generated through research conducted…
12:00–1:30 p.m. (EDT)
Antoinette Gravel-Ouellette is a Métis woman whose spirit name is Wankiya ska Shunka wanka wi, which means “white thunder horse woman.” She got involved in substance use health–related work from facing many barriers and misconceptions while…
Yakovenko, I., Stewart, S., Crocker, C., Tibbo, P., & Al-Hamdani, M.
Ottawa, April 25, 2019 — People who use cannabis regularly — one or more times per week over a period of months or years — could be at greater risk of developing psychosis or schizophrenia, according to a new report by the…
